PlainRecalls
FDA Drug Moderate Class II Terminated

EEMT HS (esterified estrogens and methyltestosterone) 0.625 mg/1.25 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-020-01

Reported: January 23, 2019 Initiated: April 17, 2017 #D-0377-2019

Product Description

EEMT HS (esterified estrogens and methyltestosterone) 0.625 mg/1.25 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-020-01

Reason for Recall

CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.

Details

Units Affected
5,000 bottles
Distribution
Product was sold to the firm's sole distributor who further distributed the product throughout the United States.
Location
Farmingdale, NY

Frequently Asked Questions

What product was recalled?
EEMT HS (esterified estrogens and methyltestosterone) 0.625 mg/1.25 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-020-01. Recalled by Syntho Pharmaceuticals, Inc.. Units affected: 5,000 bottles.
Why was this product recalled?
CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 23, 2019. Severity: Moderate. Recall number: D-0377-2019.